The global Platelet Function Test Marketis set to experience robust growth from 2025 to 2035, with its market size projected to grow from USD 1,375.8 million in 2025to USD 2,607.5 million by 2035at a ...
Is a medical journal ad for platelet-inhibition testing backed up by evidence that treatment guided by such testing can reduce the risk of clot formation? No, writes Yale cardiologist Harlan Krumholz.
Thetoday reported on the most serious infectious risks facing the blood supply: bacterial contamination of donated platelets. In its article, titled “The Biggest Blood Supply Risk: Tainted Platelets,” ...
An experimental genetic test can gauge a person's risk of developing potentially deadly blood clots, researchers report. People who scored high on the test had more than double the rate of heart ...
LOS ANGELES, CA—In patients with acute coronary syndromes (ACS) treated with prasugrel, the incidence of high on-treatment platelet reactivity depends on the type of platelet function test used, ...
The global platelet function test market is projected to be valued at USD 1.38 billion in 2025 and is expected to reach USD 2.61 billion by 2035, registering a CAGR of 6.3% during the forecast period.
The global platelet function test market is poised for robust growth over the next decade, fueled by innovations in diagnostic technologies and increasing demand for personalized, preventive ...
Thetoday reported on the most serious infectious risks facing the blood supply: bacterial contamination of donated platelets. In its article, titled “The Biggest Blood Supply Risk: Tainted Platelets,” ...